Pink Star Pellets 5-MAPB 70mg / 2-FMA 20mg / 5-MeO-MiPT 2mg
€ 35,00 – € 420,00Price range: € 35,00 through € 420,00
Pink Star Pellets are described as a multi-component laboratory research preparation associated with three named compounds: 5-MAPB, 2-FMA, and 5-MeO-MiPT.
These substances belong to different chemical families, respectively including substituted benzofurans, fluorinated amphetamine derivatives, and methoxylated tryptamines.
The supplied information describes a compressed pellet presentation intended for analytical investigation of multi-analyte chemical systems.
Relevant scientific topics include component identification, chromatographic characterization, mass-spectrometric differentiation, and examination of complex research formulations.
However, the source’s claims concerning ingredient purity, third-party testing, finished-unit composition, manufacturing consistency, and ISO-compliant production have not been independently verified.
The preparation is not established as a certified reference material or validated quantitative calibrator.
The named components should not be assumed to have interchangeable analytical characteristics, and the presence or quantity of each requires product-specific verification.
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Pink Star Pellets – 5-MAPB 70mg / 2-FMA 20mg / 5-MeO-MiPT 2mg Research Material
Product Overview
Pink Star Pellets are described in the supplied information as a multi-component laboratory research preparation associated with three synthetic compounds: 5-MAPB, 2-FMA, and 5-MeO-MiPT.
The source identifies these components as members of distinct chemical families.
5-MAPB is described as a substituted benzofuran derivative.
2-FMA is described as a fluorinated amphetamine derivative.
5-MeO-MiPT is described as a methoxylated tryptamine derivative.
These differences provide a basis for analytical investigations involving multi-analyte chemical identification, structural characterization, and chromatographic differentiation.
The supplied product is described as a compressed pellet preparation containing specified labeled amounts of the three named components.
Raw Lab Chems presents this material exclusively within a Research Use Only framework.
However, no actual batch-specific analytical report, finished-unit quantitative assay, or independent certification accompanied the information.
The labeled composition therefore remains a source-provided specification rather than an independently verified measurement.
The source also claims high ingredient purity, third-party testing, and controlled manufacturing conditions.
These claims require supporting documentation associated with the actual product and batch.
No clinical, therapeutic, diagnostic, veterinary, or consumer-oriented application is represented by this description.
Chemical Identity & Classification
Pink Star Pellets are described as a combined preparation containing three chemically distinct substances.
The supplied source identifies the components as follows:
5-MAPB
- Reported chemical name: 5-(2-Methylaminopropyl)benzofuran
- Chemical classification: Substituted benzofuran derivative
- Reported CAS Registry Number: 1354631-77-8
2-FMA
- Reported chemical name: 2-Fluoromethamphetamine
- Chemical classification: Fluorinated amphetamine derivative
- Reported CAS Registry Number: 1017176-48-5
5-MeO-MiPT
- Reported chemical name: 5-Methoxy-N-methyl-N-isopropyltryptamine
- Chemical classification: Methoxylated tryptamine derivative
- Reported CAS Registry Number: 96096-55-8
These identifiers are reproduced from the supplied source and have not been independently verified against authoritative chemical records.
The source does not provide molecular formulas, molecular weights, salt-form designations, or a complete formulation specification for the three components.
This is an important distinction because a combined preparation cannot be represented by a single molecular formula.
Each named component has its own chemical identity and associated analytical characteristics.
The finished pellet may also contain additional formulation ingredients that are not identified in the supplied information.
Researchers seeking public chemical-reference information may consult PubChem and confirm that any selected database entry corresponds to the intended compound and chemical form.
Chemical & Physical Characteristics
The supplied source describes Pink Star Pellets as compressed laboratory research preparations.
No product-specific inspection report, pellet-dimension specification, excipient list, or formulation-characterization record was provided.
The stated physical presentation therefore remains a source-provided description.
The three named components represent different chemical families with distinct molecular frameworks.
The benzofuran structure associated with 5-MAPB differs from the fluorinated amphetamine structure associated with 2-FMA.
The methoxylated tryptamine framework associated with 5-MeO-MiPT represents another distinct structural class.
These differences are relevant to analytical identification and the interpretation of multi-component chemical data.
However, structural classification alone does not establish the actual product’s purity, physical properties, stability, or analytical behavior.
The source does not provide verified melting points, quantitative solubility profiles, density measurements, or experimentally established degradation characteristics for the finished preparation.
It also does not identify the chemical forms of the individual components.
Salt forms and other formulation characteristics may affect the interpretation of ingredient quantities and analytical results.
No verified pellet dimensions, total unit mass, excipient composition, or content-uniformity measurements accompanied the supplied information.
The source recommends cool, dry storage protected from light.
No validated stability study or experimentally established shelf-life specification accompanied this recommendation.
Purity & Analytical Verification
The supplied description claims ingredient purity of at least 98% for each component, with third-party verification described as typical for the product.
However, no actual batch-specific Certificate of Analysis, chromatogram, mass spectrum, NMR spectrum, or independent laboratory report was provided.
Accordingly, the stated purity threshold is not independently confirmed for any of the three named components.
For a multi-component preparation, ingredient purity and finished-unit composition are separate analytical characteristics.
The purity of an individual chemical does not independently establish its quantity in the finished pellet.
Similarly, verification of one component does not establish the identity, purity, or quantity of the other components.
The source identifies HPLC, GC-MS, LC-MS, and NMR spectroscopy as analytical techniques associated with investigation of the mixture.
Such methods may provide information concerning chemical identity, structural characteristics, impurity profiles, and analytical specificity.
However, naming an analytical technique does not establish that it was performed on the actual product.
The source also describes the preparation as a multi-component reference material.
That description does not independently establish certified reference-material status or validated quantitative calibration performance.
No assigned measurement values, uncertainty statements, metrological traceability records, or independently verified component-specific specifications were supplied.
The preparation should therefore not be represented as a certified quantitative standard without appropriate supporting documentation.
Quality Control & Batch Integrity
The supplied source claims that Pink Star Pellets undergo third-party analytical verification and batch-specific quality assurance.
It also refers to Certificates of Analysis, independent component testing, traceability records, and ISO-compliant production.
No actual certificate, independent testing record, manufacturing audit, laboratory accreditation document, or batch-specific quality-control report accompanied these statements.
They therefore remain unverified supplier claims.
For reproducible laboratory investigation, useful records may include supplier identification, batch number, chemical identifiers, receipt date, storage history, and available analytical findings.
For a multi-component pellet, the identity and purity of each named ingredient should be distinguished from the composition and consistency of the finished units.
The supplied information does not establish independently verified content uniformity, excipient composition, or quantitative accuracy of the labeled component amounts.
The claim of ISO-compliant production is also insufficient to establish certification or accreditation.
No certification number, scope, issuing body, or supporting audit documentation was provided.
Where a material is described as suitable for reference-standard work, researchers should distinguish ordinary catalog material from a certified reference material.
Claims of consistent purity, identity, formulation quality, or manufacturing compliance should be supported by actual analytical records rather than inferred from promotional terminology.
Safety, Handling & Laboratory Precautions
Pink Star Pellets are described as containing multiple pharmacologically active research chemicals belonging to different structural families.
The combined toxicological profile of the finished preparation has not been established by the supplied information.
Research personnel should consult available chemical-safety documentation and institutional procedures before receiving or examining the material.
Laboratory precautions should address access restrictions, protective equipment, contamination prevention, accidental exposure, environmental release, and chemical-waste disposal.
The presence of multiple named components introduces additional uncertainty when the actual formulation, chemical forms, and impurity profile have not been independently confirmed.
Structural classification does not establish safety for human or veterinary exposure.
The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments. Pink Star Pellets
Because the actual composition and purity have not been independently confirmed, laboratory documentation should distinguish verified characteristics from supplier-provided statements.
Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.
Packaging, Labeling & Storage
The supplied source describes secure packaging, appropriate labeling, shipment tracking, and professional international transportation.
No packaging-validation study, verified container specification, actual shipment-condition record, or carrier documentation accompanied these claims.
The source recommends cool, dry storage protected from light, with a suggested temperature range of 2–8°C for longer-term preservation.
No validated stability data was provided to establish that this temperature range is necessary or sufficient for the finished multi-component preparation.
The source also claims that shipping arrangements support international laboratory requirements.
No shipment classification, destination-specific regulatory authorization, or customs documentation was supplied to substantiate those statements.
Laboratory inventory records should preserve the product designation, any available batch identifier, receipt details, and relevant storage observations.
The labeled component amounts should be recorded as source-provided specifications unless independently confirmed.
Where chemical forms or formulation ingredients remain uncertain, the inventory record should preserve those uncertainties rather than assign unverified details.
Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional laboratory procedures.
Intended Research Use & Market Positioning
The supplied scientific context places Pink Star Pellets within analytical research involving multi-component chemical systems, substituted benzofurans, fluorinated amphetamine derivatives, and methoxylated tryptamines.
The three named components provide a basis for laboratory investigation of chemical identity and differentiation within complex analytical samples.
The source references chromatographic identification, mass-spectrometric characterization, and comparative examination of distinct chemical classes.
These references describe laboratory research contexts and do not establish any human-use application. Pink Star Pellets
The supplied Raw Lab Chems catalog includes Pink Star Pellets, corresponding to the preparation discussed here.
The catalog also includes Blue Bliss Pellets, another listed preparation associated with the same three named compounds but different labeled component quantities.
A separate catalog entry, MaXTC Blister, identifies 4-FMA rather than 2-FMA.
These fluorinated amphetamine derivatives are different named substances and should not be treated as chemically identical or analytically interchangeable.
The supplied information does not establish equivalent chemical forms, ingredient purity, or finished-unit analytical characteristics across these listings.
These references provide catalog context rather than evidence of certified reference-material status or product interchangeability.
Ordering, Availability & Fulfillment
The supplied source describes standardized laboratory units, protective packaging, and professional international shipping arrangements.
However, no current inventory information, carrier record, destination-specific authorization, or verified shipment-performance documentation was provided.
Consequently, no specific availability, delivery, customs-clearance, or transportation-compliance guarantee is asserted. Pink Star Pellets
The named components may be subject to controlled-substance, analogue, pharmaceutical, or other chemical regulations depending on the jurisdiction.
The legal classification of a combined preparation may also depend on its actual composition and the laws governing each component.
Institutional acquisition and transfer should therefore be assessed against the applicable laws governing the exact substances and chemical forms involved.
Researchers and institutions should independently verify whether possession, importation, exportation, transportation, and laboratory investigation are authorized in their jurisdictions.
Research-only labeling does not establish an exemption from controlled-substance regulations.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Pink Star Pellets are described as a combined preparation containing 5-MAPB, 2-FMA, and 5-MeO-MiPT.
These substances and the finished preparation may be subject to controlled-substance, analogue, pharmaceutical, or other chemical regulations.
Their acquisition, possession, transfer, importation, exportation, storage, and laboratory investigation may be restricted or prohibited depending on the jurisdiction.
The exact legal classification and requirements may vary by location and by the actual chemical forms involved. Pink Star Pellets
Researchers and institutions remain responsible for determining the applicable legal requirements and obtaining any necessary authorizations.
No medical approval, consumer-use authorization, universal legal status, or regulatory exemption is implied by this description.
| Quantity (pellets) |
5 ,10 ,25 ,50 ,100 |
|---|
You must be logged in to post a review.

Reviews
There are no reviews yet.